Clinical Trials Directory

Trials / Completed

CompletedNCT01013155

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions

A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fed Conditions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Roxane Laboratories · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablet under fed conditions

Conditions

Interventions

TypeNameDescription
DRUGperindopril erbumine8 mg tablet

Timeline

Start date
2007-05-01
Primary completion
2007-05-01
Completion
2007-05-01
First posted
2009-11-13
Last updated
2018-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01013155. Inclusion in this directory is not an endorsement.